16 Equity

Accounting policy

dsm-firmenich classifies ordinary shares and other financial instruments, for which settlement of the contractual obligations is at the sole discretion of dsm-firmenich, as equity. 

The price paid for repurchased dsm-firmenich shares (treasury shares) is deducted from dsm-firmenich shareholders’ equity until the shares are reissued. Treasury shares are presented in the treasury share reserve. When treasury shares are sold or reissued, the amount received is recognized as an increase in equity.

Dividend to be distributed to holders of ordinary shares is recognized as a liability when the Annual General Meeting of Shareholders approves the profit appropriation.

Movements in equity

 

 

2023

 

2022

Balance at 1 January

 

10,845

 

9,397

 

 

 

 

 

Net profit for the year

 

2,153

 

1,715

Other comprehensive income

 

30

 

227

Options/share units granted

 

23

 

34

Dividend

 

(582)

 

(459)

Proceeds from issuance of new ordinary shares

 

11,510

 

-

Expenditures related to issuance of new shares

 

(29)

 

-

Proceeds from reissue of ordinary shares

 

24

 

141

Acquisition of NCI without a change in control

 

48

 

-

Acquisition (divestment) of subsidiary with NCI

 

(4)

 

(4)

Repurchase of shares

 

(256)

 

(210)

Liability i.r.t. buy-out non-tendered shares DSM N.V.

 

(649)

 

-

Other changes

 

(43)

 

4

Balance at 31 December

 

23,070

 

10,845

Share capital

On 31 December 2023, the capital amounted to €2.7 million, consisting of 265.7 million ordinary shares. All DSM-Firmenich AG shares have a nominal value of €0.01 each. The outstanding shares provide an entitlement of one vote per share at the General Meeting of Shareholders. All rights attached to the company’s shares held by the Group (treasury shares) are suspended until those shares are reissued.

Share capital movements

 

 

Date of issuance

 

Quantity

 

Issue price/share (in €)

 

Nominal value1 (in € million)

 

Share premium (in € million)

 

Total issuance value (in € million)

DSM N.V. shares swapped into dsm-firmenich shares – 1st offer period

 

20 April 2023

 

150,742,711

 

 

 

 

 

 

 

 

DSM N.V. shares swapped into dsm-firmenich shares – 2nd offer period

 

3 May 2023

 

16,578,846

 

 

 

 

 

 

 

 

Issued dsm-firmenich shares – compensate for non-tendered shares DSM N.V.

 

8 May 2023

 

6,696,477

 

109.50

 

0

 

733

 

733

Issued dsm-firmenich shares – issued to shareholders Firmenich International SA

 

8 May 2023

 

91,658,354

 

117.58

 

1

 

10,776

 

10,777

Total

 

 

 

 

 

 

 

 

 

 

 

11,510

1

Nominal value per DSM-Firmenich AG share is €0.01.

In 2023, a total of 167.3 million DSM N.V. shares were exchanged for DSM-Firmenich AG shares (ratio 1:1), 6.7 million new shares were issued and placed in the stock market, and 91.7 million DSM-Firmenich AG new shares were granted to the former Firmenich owners. All shares issued are fully paid.

A number of 6.7 million DSM N.V. shares were not tendered; the company has commenced a statutory buy-out procedure to acquire these shares, and recognized a liability of €649 million at the end of the reporting period.

Prior to the merger, Koninklijke DSM N.V. was the parent of the Group. The changes in the number of issued and outstanding shares in 2022 and 2023 until 8 May are shown in the following table.

Development issued and outstanding shares Koninklijke DSM N.V.

 

 

Issued shares

 

Treasury shares

 

Treasury shares

 

 

Ordinary

 

Cumprefs A

 

Ordinary

Balance at 1 January 2022

 

174,786,029

 

44,040,000

 

1,817,299

 

 

 

 

 

 

 

Reissue of shares in connection with share‑based payments

 

 

 

 

 

(617,967)

Repurchase of shares

 

 

 

 

 

1,330,000

Dividend in the form of ordinary shares

 

 

 

 

 

(818,700)

Balance at 31 December 2022

 

174,786,029

 

44,040,000

 

1,710,632

 

 

 

 

 

 

 

Number of treasury shares at 31 December 2022

 

(1,710,632)

 

 

 

 

Number of shares outstanding at 31 December 2022

 

173,075,397

 

44,040,000

 

 

 

 

 

 

 

 

 

Balance at 1 January 2023

 

174,786,029

 

44,040,000

 

1,710,632

 

 

 

 

 

 

 

Reissue of shares in connection with share‑based payments

 

 

 

 

 

(280,021)

Shares DSM N.V. swapped to DSM-Firmenich AG shares

 

(167,321,557)

 

 

 

(662,616)

Cancellation of shares

 

(767,995)

 

(44,040,000)

 

(767,995)

Non-tendered shares recognized as liability

 

(6,696,477)

 

 

 

 

Balance at 31 December 2023

 

-

 

-

 

-

On 28 April 2023, 44.0 million outstanding Cumulative preference shares A Koninklijke DSM N.V. were repurchased for the amount of €256 million. On 31 May 2023, all Cumulative preference shares A and C were canceled.

As of the completion of the merger, DSM-Firmenich AG is the new parent of the Group. The changes in the number of issued and outstanding shares starting 8 May are shown in the following table.

Development issued and outstanding shares DSM-Firmenich AG

 

 

Issued shares

 

Treasury shares

 

 

Ordinary

 

Ordinary

Balance at 1 January 2023

 

-

 

-

 

 

 

 

 

Issue of new shares via tender process

 

167,321,557

 

 

Issue of new shares via placement in the market

 

98,354,831

 

 

Swap treasury shares DSM N.V. to DSM-Firmenich AG

 

 

 

662,616

Reissue of shares in connection with share-based payments

 

 

 

(270,044)

Balance at 31 December 2023

 

265,676,388

 

392,572

 

 

 

 

 

Number of treasury shares at 31 December 2023

 

(392,572)

 

 

Number of shares outstanding at 31 December 2023

 

265,283,816

 

 

Share premium

The share premium increased by €11,260 million mainly due to the issuance of new shares (€11,758 million), partly offset by the dividend distribution out of share premium on 6 July 2023 of €425 million by DSM-Firmenich AG.

Treasury shares

In 2023, the Group did not repurchase own shares to fulfill its obligations under the share-based compensation plans. At 31 December 2023, dsm-firmenich possessed 0.4 million ordinary shares, or 0.15% of the share capital, for servicing share-option rights and share plans. The average purchase price of the ordinary treasury shares as at 31 December 2023 was €112.34.

Other reserves in Shareholders’ equity

 

 

Translation reserve

 

Hedging reserve

 

Reserve for share-based compensation

 

Fair value reserve

 

Total

Balance at 1 January 2022

 

177

 

(77)

 

39

 

17

 

156

 

 

 

 

 

 

 

 

 

 

 

Changes:

 

 

 

 

 

 

 

 

 

 

Fair-value changes of derivatives

 

-

 

(6)

 

-

 

-

 

(6)

Release to income statement

 

(16)

 

53

 

-

 

-

 

37

Fair-value changes of other financial assets

 

-

 

-

 

-

 

(61)

 

(61)

Exchange differences

 

267

 

-

 

-

 

-

 

267

Options and performance shares granted

 

-

 

-

 

34

 

-

 

34

Options and performance shares exercised/canceled

 

-

 

-

 

(29)

 

-

 

(29)

Transfer to retained earnings

 

-

 

-

 

-

 

(28)

 

(28)

Income tax

 

(4)

 

(3)

 

-

 

-

 

(7)

Total changes

 

247

 

44

 

5

 

(89)

 

207

 

 

 

 

 

 

 

 

 

 

 

Balance at 31 December 2022

 

424

 

(33)

 

44

 

(72)

 

363

 

 

 

 

 

 

 

 

 

 

 

Changes:

 

 

 

 

 

 

 

 

 

 

Fair-value changes of derivatives

 

-

 

34

 

-

 

-

 

34

Release to income statement

 

6

 

(7)

 

-

 

-

 

(1)

Fair-value changes of other financial assets

 

-

 

-

 

-

 

(65)

 

(65)

Exchange differences

 

144

 

-

 

-

 

-

 

144

Options and performance shares granted

 

-

 

-

 

23

 

-

 

23

Options and performance shares exercised/canceled

 

-

 

-

 

(23)

 

-

 

(23)

Transfer to retained earnings

 

-

 

-

 

-

 

(5)

 

(5)

Income tax

 

-

 

(1)

 

-

 

5

 

4

Total changes

 

150

 

26

 

-

 

(65)

 

111

 

 

 

 

 

 

 

 

 

 

 

Balance at 31 December 2023

 

574

 

(7)

 

44

 

(137)

 

474

The increase in the Translation reserve in 2023 is mainly caused by a weakening of the euro against the Swiss franc versus a strengthening against the US dollar and Chinese renminbi. As a consequence, the total value of the subsidiaries increased, which led to a positive exchange difference of €144 million.

Additional information on the reserves is provided in Note 6 Share capital to the Parent company financial statements.

Dividend

Prior to the merger, dividend was paid to the holders of cumulative preference shares A and of non-tendered ordinary shares of Koninklijke DSM N.V. In the subsequent period, the Group paid a dividend to the holders of ordinary shares of DSM-Firmenich AG.

Dividend distribution in the reporting year

 

 

2023

 

2022

Shareholders Koninklijke DSM N.V.

 

 

 

 

Per cumulative preference share A: €0.14 (2022: €0.13)

 

6

 

6

Interim dividend ordinary shares: (2022: 0.93)

 

-

 

161

Final dividend ordinary shares: €22.58 (2022: €1.70)

 

151

 

292

 

 

 

 

 

Shareholders DSM-Firmenich AG

 

 

 

 

Per ordinary share: €1.60

 

425

 

 

Total

 

582

 

459

Deeply subordinated fixed rate resettable perpetual notes

Firmenich International SA issued deeply subordinated fixed rate resettable perpetual notes for the amount of €750 million on 3 June 2020 with a coupon of 3.75% payable annually at the sole discretion of the issuer until the first reset date i.e. 3 September 2025. Thereafter, the interest rate is reset every 5 years. In 2023, the remuneration on the deeply subordinated fixed rate resettable perpetual notes amounts to €28 million. In accordance with the provisions of IAS 32 Financial Instruments – Presentation, this instrument is accounted for in equity.

Topic filter

Results